AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,728 | -14.9% | 1,129,189 | -8.2% | 0.00% | 0.0% |
| Q2 2023 | $2,030 | +243.5% | 1,230,196 | +137.1% | 0.00% | +200.0% |
| Q1 2023 | $591 | +41.7% | 518,800 | +12.1% | 0.00% | 0.0% |
| Q4 2022 | $417 | -100.0% | 462,737 | -48.6% | 0.00% | 0.0% |
| Q3 2022 | $1,054,000 | +34.3% | 900,800 | -26.5% | 0.00% | 0.0% |
| Q2 2022 | $785,000 | +772.2% | 1,226,400 | +3475.5% | 0.00% | – |
| Q1 2022 | $90,000 | +104.5% | 34,300 | +204.7% | 0.00% | – |
| Q4 2021 | $44,000 | -94.7% | 11,257 | -94.1% | 0.00% | -100.0% |
| Q3 2021 | $827,000 | -15.1% | 189,669 | -22.7% | 0.00% | 0.0% |
| Q2 2021 | $974,000 | -33.0% | 245,448 | -9.7% | 0.00% | -50.0% |
| Q4 2020 | $1,454,000 | +125.8% | 271,800 | -7.6% | 0.00% | +100.0% |
| Q1 2020 | $644,000 | +40.0% | 294,051 | +272.2% | 0.00% | – |
| Q4 2019 | $460,000 | – | 79,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $36,580,000 | 71.47% |
| WEDBUSH SECURITIES INC | 98,489 | $313,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 29,536 | $94,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 72,296 | $230,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 114,211 | $363,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $191,000 | 0.00% |
| Baker Brothers Advisors | 99,600 | $317,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 8,129 | $26,000 | 0.00% |
| Squarepoint Ops LLC | 40,777 | $130,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 100,089 | $318,000 | 0.00% |